glp-1 obesity drug news today oct 23 2025 New oral delivers up to 12% weight loss in 36 weeks Obesity GLP-1 Market

All of our supplements are manufactured in the USA

Shima Hadidchi, MD, in Apple Valley and Victorville, CA

Across the dataset, a few patterns stood out: Zepboundposts mention fatigue, constipation, and hair thinning more than any other drug

Tirzepatide, characterized by its ability to selectively bind and activate receptors for the intestinal hormones GIP and GLP-1, has been tested in numerous clinical studies and is already currently authorized in several countries for the treatment of type 2 diabetes and obesity

So how can he increase our GLP-1 naturally?

Why the hype: Diabetes, obesity, and vascular disease are known contributors to brain aging and dementia risk